Commercialisation Executive, Faculty of Natural Sciences

Edmond Yau is a Commercialisation Executive at Imperial College London, managing intellectual property and licensing activities for the Faculty of Natural Sciences. He supports the assessment, protection and commercialisation of academic innovations, guiding technologies from discovery to market through licensing, IP strategy and industry engagement.

Before joining Imperial, Edmond spent over a decade at The Hong Kong University of Science and Technology and The Chinese University of Hong Kong, managing hundreds of inventions and thousands of patent applications. A qualified patent agent in China, he holds a degree in Chemical Engineering and a Master of Laws in Intellectual Property from the University of London. Fluent in English, Cantonese and Mandarin, he bridges global academia and industry in advancing scientific innovation.

Edmond's portfolio

Discover all technologies

Novel vortex laser

Interferometric coupler enables high-power, efficient vortex laser beams for optical manipulation, communications, encryption, and retrofitting existing systems

A technique to detect and discriminate mycobacteria using intact cell lipidomics

Easy to implement control methodology for improved grade and recovery

Enhanced Light Extraction from Light Emitting Diodes Utilizing a Nanoparticle Meta Grid

Nanoparticle meta-grid boosts LED light output by 15–18%, reducing heat and simplifying manufacturing for longer-lasting, efficient devices. [imperial.tech]

Dual-View Oblique Plane Microscopy

Compact dual-view microscopy system enhances resolution and reduces artefacts via folded optics and two-view deconvolution for clearer imaging

Mid-infrared pulse laser for biological applications

A system designed for generating ultrafast mid-infrared laser pulses at the wavelength at which water molecules absorb light resonantly

Genetic constructs for localised population suppression of pest species

Genome-editing constructs induce dominant lethal mutations, enabling efficient, localised suppression of pest populations across diverse species

Microbiome therapeutics to inhibit the growth of CRE and VRE

A proposed microbiome therapeutic against CRE and VRE, comprising a synthetic microbial consortium and inhibitory metabolites.

Polymers with Anti-Microbial Properties

A new way to manufacture plastics with anti-microbial properties.

Long-lasting nanoparticles for controlled release drug delivery

A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.

High power single mode nanolaser arrays

A high-powered, single mode nanolaser technology for integrated photonic communication chips and LIDAR systems.

citrOgen – the first universal presentation platform for bacterial antigens

Rapid antibody platform targets diverse bacteria, accelerating monoclonal development and vaccine antigen evaluation workflows.

PolSpec: Versatile optical spectral imaging

Polarisation-based detection enables versatile (hyper)spectral imaging across microscopy, pathology, endoscopy, and remote sensing.

Enhancing quantum memories by means of Light-Matter Interference (EEVI)

Quantum memory protocol improves efficiency in storage and retrieval without increasing control power or optical depth.

Polypeptide “Warhead” Targeting MYC for Cancer Therapy

Polypeptide-based (‘bioPROTAC’) technology to degrade the MYC oncoprotein inside cells, applicable in cancer treatment and prevention.

EffiTrap: comprehensive and real-time defect analysis for semiconductors

Technology for advanced defect analysis in semiconductors, sensors, photonics, laser materials, and photovoltaics.